Cedric O'gorman - Net Worth and Insider Trading
Cedric O'gorman Net Worth
The estimated net worth of Cedric O'gorman is at least $3,876 dollars as of 2024-12-29. Cedric O'gorman is the Chief Medical Officer of Relmada Therapeutics Inc and owns about 10,121 shares of Relmada Therapeutics Inc (RLMD) stock worth over $3,876. Details can be seen in Cedric O'gorman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cedric O'gorman has not made any transactions after 2023-05-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cedric O'gorman
Cedric O'gorman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cedric O'gorman owns 1 companies in total, including Relmada Therapeutics Inc (RLMD) .
Click here to see the complete history of Cedric O'gorman’s form 4 insider trades.
Insider Ownership Summary of Cedric O'gorman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RLMD | Relmada Therapeutics Inc | 2023-05-23 | Chief Medical Officer |
Cedric O'gorman Latest Holdings Summary
Cedric O'gorman currently owns a total of 1 stock. Cedric O'gorman owns 10,121 shares of Relmada Therapeutics Inc (RLMD) as of May 23, 2023, with a value of $3,876.
Latest Holdings of Cedric O'gorman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RLMD | Relmada Therapeutics Inc | 2023-05-23 | 10,121 | 0.38 | 3,876 |
Holding Weightings of Cedric O'gorman
Cedric O'gorman Form 4 Trading Tracker
According to the SEC Form 4 filings, Cedric O'gorman has made a total of 1 transactions in Relmada Therapeutics Inc (RLMD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Relmada Therapeutics Inc is the acquisition of 10,000 shares on May 23, 2023, which cost Cedric O'gorman around $31,800.
Insider Trading History of Cedric O'gorman
- 1
Cedric O'gorman Trading Performance
GuruFocus tracks the stock performance after each of Cedric O'gorman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cedric O'gorman is -6.39%. GuruFocus also compares Cedric O'gorman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cedric O'gorman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cedric O'gorman's insider trading performs compared to the benchmark.
Performance of Cedric O'gorman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -21.09 | | | | | |
| Relative Return to S&P 500(%) | -25.98 | | | | | |
Cedric O'gorman Ownership Network
Cedric O'gorman Owned Company Details
What does Relmada Therapeutics Inc do?
Who are the key executives at Relmada Therapeutics Inc?
Cedric O'gorman is the Chief Medical Officer of Relmada Therapeutics Inc. Other key executives at Relmada Therapeutics Inc include director & Chief Executive Officer Sergio Traversa , Chief Financial Officer Chuck Ence , and EVP & Head of R&D Thomas Wessel .
Relmada Therapeutics Inc (RLMD) Insider Trades Summary
Over the past 18 months, Cedric O'gorman made no insider transaction in Relmada Therapeutics Inc (RLMD). Other recent insider transactions involving Relmada Therapeutics Inc (RLMD) include a net purchase of 240,000 shares made by Sergio Traversa , a net purchase of 86,107 shares made by Maged Shenouda , and a net purchase of 38,970 shares made by Chuck Ence .
In summary, during the past 3 months, insiders sold 0 shares of Relmada Therapeutics Inc (RLMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Relmada Therapeutics Inc (RLMD) were sold and 403,077 shares were bought by its insiders, resulting in a net purchase of 403,077 shares.
Relmada Therapeutics Inc (RLMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Relmada Therapeutics Inc Insider Transactions
Cedric O'gorman Mailing Address
Above is the net worth, insider trading, and ownership report for Cedric O'gorman. You might contact Cedric O'gorman via mailing address: C/o Relmada Therapeutics, Inc., 2222 Ponce De Leon Blvd, 3rd Floor, Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
